Supplementation with branched-chain amino acids inhibits azoxymethane-induced colonic preneoplastic lesions in male C57BL/KsJ-db/db mice. [electronic resource]
- Clinical cancer research : an official journal of the American Association for Cancer Research May 2009
- 3068-75 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1078-0432
10.1158/1078-0432.CCR-08-2093 doi
Amino Acids, Branched-Chain--therapeutic use Animals Azoxymethane--toxicity Body Weight--drug effects Carcinogens--toxicity Colonic Neoplasms--chemically induced Diabetes Mellitus, Experimental--drug therapy Dietary Supplements Insulin--blood Insulin-Like Growth Factor I--metabolism Insulin-Like Growth Factor II--metabolism Male Mice Mice, Inbred C57BL Mice, Nude Obesity--drug therapy Organ Size--drug effects Precancerous Conditions--chemically induced Proliferating Cell Nuclear Antigen--metabolism Receptor, IGF Type 1--metabolism Receptor, IGF Type 2--metabolism Tumor Cells, Cultured beta Catenin--metabolism